ATLASCorvus Pharmaceuticals (CRVS) earnings date: Nov 5, 2026
Corvus Pharmaceuticals (CRVS) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.21.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CRVS
| Last price | $9.69 (-3.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Corvus Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Corvus Pharmaceuticals reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Corvus Pharmaceuticals. You can switch it off at any time.
Alert me before CRVS reportsFree to start. Creating an account takes under a minute.
Notify me when Corvus Pharmaceuticals reports
Track CRVS free Add Corvus Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
CRVS earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.21 |
| Last report | Aug 6, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -3.1% |
| Average move around a report | ±3.5% (last 5) |
| Sector | Healthcare · Biotechnology |
Corvus Pharmaceuticals earnings history: last 5 reports
Corvus Pharmaceuticals last reported on Aug 6, 2026: EPS of -$0.19 against an estimate of -$0.17 (-11.8% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.17 | -$0.19 | -11.8% | Miss | -0.1% |
| May 7, 2026 | -$0.15 | -$0.15 | 0.0% | In line | +0.7% |
| Mar 12, 2026 | -$0.13 | -$0.15 | -15.4% | Miss | -9.4% |
| Feb 12, 2026 | $1.03 | $1.07 | +3.9% | Beat | -5.5% |
| Nov 4, 2025 | -$0.13 | -$0.12 | +7.7% | Beat | -2.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CRVS
See the fair value, the probability range and the earnings history of Corvus Pharmaceuticals on its ATLAS page.
Corvus Pharmaceuticals (CRVS) stock analysisPlans from €3.99 a month.
Corvus Pharmaceuticals earnings: frequently asked questions
When does Corvus Pharmaceuticals (CRVS) report earnings?
Corvus Pharmaceuticals is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CRVS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.21 per share (USD). Estimates can change before the report.
How often does CRVS beat earnings estimates?
Of its last 5 reports with a recorded result, Corvus Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -3.1%. Past results do not predict the next one.
How much does CRVS move around earnings?
Over its last 5 reports the stock moved an average of 3.5% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Corvus Pharmaceuticals beat earnings estimates last quarter?
Corvus Pharmaceuticals last reported on Aug 6, 2026: EPS of -$0.19 against an estimate of -$0.17 (-11.8% surprise), a miss.
How much does CRVS usually move in a day?
On a normal trading day the ATLAS model puts CRVS’s one-day range at about ±3.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer